238 related articles for article (PubMed ID: 26380951)
1. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.
Shah N; Frey KA; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Bohnen NI
Mov Disord; 2016 Jan; 31(1):111-7. PubMed ID: 26380951
[TBL] [Abstract][Full Text] [Related]
2. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.
Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Constantine GM; Scott PJ; Albin RL; Müller ML
Mov Disord; 2014 Aug; 29(9):1118-24. PubMed ID: 24909584
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
Bohnen NI; Kotagal V; Müller ML; Koeppe RA; Scott PJ; Albin RL; Frey KA; Petrou M
Parkinsonism Relat Disord; 2014 Dec; 20(12):1394-8. PubMed ID: 25454317
[TBL] [Abstract][Full Text] [Related]
4. Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline.
Zhou Z; Müller MLTM; Kanel P; Chua J; Kotagal V; Kaufer DI; Albin RL; Frey KA; Bohnen NI
Neurology; 2020 Jan; 94(4):e376-e383. PubMed ID: 31732566
[TBL] [Abstract][Full Text] [Related]
5. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.
Müller ML; Frey KA; Petrou M; Kotagal V; Koeppe RA; Albin RL; Bohnen NI
Mov Disord; 2013 Mar; 28(3):296-301. PubMed ID: 23239424
[TBL] [Abstract][Full Text] [Related]
6. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.
Bohnen NI; Albin RL; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Frey KA
JAMA Neurol; 2015 Feb; 72(2):194-200. PubMed ID: 25506674
[TBL] [Abstract][Full Text] [Related]
7. The correlation between striatal and cortical binding ratio of
Sauerbeck J; Ishii K; Hosokawa C; Kaida H; Scheiwein FT; Hanaoka K; Rominger A; Brendel M; Bartenstein P; Murakami T
Ann Nucl Med; 2018 Jul; 32(6):398-403. PubMed ID: 29730823
[TBL] [Abstract][Full Text] [Related]
8. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
9. Gait speed in Parkinson disease correlates with cholinergic degeneration.
Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Müller ML
Neurology; 2013 Oct; 81(18):1611-6. PubMed ID: 24078735
[TBL] [Abstract][Full Text] [Related]
10. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
[TBL] [Abstract][Full Text] [Related]
11. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.
Petrou M; Bohnen NI; Müller ML; Koeppe RA; Albin RL; Frey KA
Neurology; 2012 Sep; 79(11):1161-7. PubMed ID: 22933741
[TBL] [Abstract][Full Text] [Related]
12. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
13. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
14. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
[TBL] [Abstract][Full Text] [Related]
15. Mentally stimulating activities associate with better cognitive performance in Parkinson disease.
Bohnen JLB; Müller MLTM; Haugen J; Bohnen NI
J Neural Transm (Vienna); 2017 Oct; 124(10):1205-1212. PubMed ID: 28726034
[TBL] [Abstract][Full Text] [Related]
16. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Preboske GM; Kantarci K; Raman MR; Machulda MM; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Rocca WA; Roberts RO; Petersen RC; Jack CR
Brain; 2015 Mar; 138(Pt 3):761-71. PubMed ID: 25595145
[TBL] [Abstract][Full Text] [Related]
17. Amyloid imaging of Lewy body-associated disorders.
Foster ER; Campbell MC; Burack MA; Hartlein J; Flores HP; Cairns NJ; Hershey T; Perlmutter JS
Mov Disord; 2010 Nov; 25(15):2516-23. PubMed ID: 20922808
[TBL] [Abstract][Full Text] [Related]
18. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.
Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MA; Albin RL; Frey KA
Brain; 2010 Jun; 133(Pt 6):1747-54. PubMed ID: 20413575
[TBL] [Abstract][Full Text] [Related]
19. Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease.
Kotagal V; Bohnen NI; Müller ML; Frey KA; Albin RL
J Parkinsons Dis; 2017; 7(1):143-147. PubMed ID: 28106566
[TBL] [Abstract][Full Text] [Related]
20. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
Frings L; Hellwig S; Spehl TS; Bormann T; Buchert R; Vach W; Minkova L; Heimbach B; Klöppel S; Meyer PT
Brain; 2015 Oct; 138(Pt 10):3089-99. PubMed ID: 26280595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
